Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-28

Clinical Trial Update: To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg [Phase 1]

View source ↗

Summary

A Phase 1 trial by Sandoz to demonstrate the relative bioavailability of atenolol 100 mg tablets for angina and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atenolol (Atenolol)

Snippet

Sponsor: Sandoz | Conditions: Angina, Hypertension | Phase 1 | Status: COMPLETED